Dye & Durham (TSE:DND – Get Free Report) had its price target decreased by CIBC from C$25.00 to C$21.00 in a research report issued on Wednesday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. CIBC’s price objective points to a potential upside of 159.26% from the company’s previous close.
A number of other research analysts have also commented on DND. Scotiabank lowered their price objective on Dye & Durham from C$25.00 to C$20.00 in a report on Friday, February 14th. BMO Capital Markets lowered their target price on shares of Dye & Durham from C$22.00 to C$20.00 in a research note on Friday, February 14th. Canaccord Genuity Group dropped their target price on shares of Dye & Durham from C$27.50 to C$23.00 in a report on Friday, February 14th. Finally, Cormark downgraded Dye & Durham from a “moderate buy” rating to a “hold” rating in a research report on Friday, February 14th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of C$21.93.
View Our Latest Stock Analysis on DND
Dye & Durham Stock Down 4.0 %
Insider Activity at Dye & Durham
In other news, insider Plantro Ltd. sold 1,778,900 shares of Dye & Durham stock in a transaction that occurred on Thursday, January 16th. The stock was sold at an average price of C$15.16, for a total transaction of C$26,967,768.22. Corporate insiders own 25.60% of the company’s stock.
Dye & Durham Company Profile
Dye & Durham Ltd is engaged in providing cloud-based software and technology solutions designed to improve efficiency and increase productivity for legal and business professionals. The company has business operations in Canada and the United Kingdom. The customers include law firms, financial service institutions, and government organizations.
Featured Stories
- Five stocks we like better than Dye & Durham
- NYSE Stocks Give Investors a Variety of Quality Options
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- How to Invest in Small Cap Stocks
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- How to Invest in Blue Chip Stocks
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Dye & Durham Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dye & Durham and related companies with MarketBeat.com's FREE daily email newsletter.